wordpress blog stats
Connect with us

Hi, what are you looking for?

Pharmeasy raises $50 million in Series C funding

Healthcare startup Pharmeasy has raised $50 million in a Series C round, led by Eight Roads Ventures India, F-Prime Capital, Fundamentum Partnership backed by Nandan Nilekani and Sanjeev Aggarwal, and US-based Think Investments. Existing investor Bessemer Venture Partners also participated in the round. The funding was reported by Mint.

The funds will reportedly be used to increase customer base, expand warehouses and fulfillment centres, among other things. It already has 8 existing warehouses in the country, and plans to open 12 by 2019.

Co-founder Dhaval Shah told Mint that the funds will also be invested to branch out into chronic care management and digital records.

Pharmeasy currently operates in delivery of medicines, diagnostic tests and health & wellness products.

Previous funding

  • It reportedly raised $5.5 million in debt earlier this month from InnoVen Capital.
  • According to ET, the startup raised around $30 million in March 2018, in a round led by Bessemer Venture Partners with participation from Orios Venture Partners, JM Financial, Manipal Education and Medical Group (MEMG) and Trifecta Capital.
  • The startup raised $16 million in a Series B round in March 2017 from existing investors.
  • Pharmeasy raised $5 million in a Series A round in 2016 from Bessemer Venture Partners, Orios Venture Partners and others.

Advertisement. Scroll to continue reading.
Written By

I cover health, policy issues such as intermediary liability, data governance, internet shutdowns, and more. Hit me up for tips.

MediaNama’s mission is to help build a digital ecosystem which is open, fair, global and competitive.



Looking at the definition of health data, it is difficult to verify whether health IDs are covered by the Bill.


The accession to the Convention brings many advantages, but it could complicate the Brazilian stance at the BRICS and UN levels.


In light of the state's emerging digital healthcare apparatus, how does Clause 12 alter the consent and purpose limitation model?


The collective implication of leaving out ‘proportionality’ from Clause 12 is to provide very wide discretionary powers to the state.


The latest draft is also problematic for companies or service providers that have nothing to with children's data.

You May Also Like


Google has released a Google Travel Trends Report which states that branded budget hotel search queries grew 179% year over year (YOY) in India, in...


135 job openings in over 60 companies are listed at our free Digital and Mobile Job Board: If you’re looking for a job, or...


Rajesh Kumar* doesn’t have many enemies in life. But, Uber, for which he drives a cab everyday, is starting to look like one, he...


By Aroon Deep and Aditya Chunduru You’re reading it here first: Twitter has complied with government requests to censor 52 tweets that mostly criticised...

MediaNama is the premier source of information and analysis on Technology Policy in India. More about MediaNama, and contact information, here.

© 2008-2021 Mixed Bag Media Pvt. Ltd. Developed By PixelVJ

Subscribe to our daily newsletter
Your email address:*
Please enter all required fields Click to hide
Correct invalid entries Click to hide

© 2008-2021 Mixed Bag Media Pvt. Ltd. Developed By PixelVJ